Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

98.050
+2.1502.24%
Volume:16.81M
Turnover:1.64B
Market Cap:171.10B
PE:208.62
High:99.350
Open:95.150
Low:94.800
Close:95.900
52wk High:112.700
52wk Low:69.550
Shares:1.75B
HK Float Shares:1.75B
Volume Ratio:1.98
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.470
ROE:7.01%
ROA:2.23%
PB:7.06
PE(LYR):208.62
PS:9.32

Loading ...

Hong Kong Stocks Open Flat as Pharma Shares Lead Gains; Innovent Rises Nearly 2%

Stock News
·
Sep 21

Movement Alert|INNOVENT BIO Rises 3.62% in Regular Trading, Strong H1 Earnings and WCLC Data Catalysts Boost Sentiment

Market Focus
·
Sep 21

Is Innovent Biologics (SEHK:1801) Fairly Valued On LP 003 China BLA Progress?

Simply Wall St.
·
Sep 15

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Innovent's Enlarged Cash Holdings, Investment Fair Value Could Boost Earnings

Dow Jones
·
Sep 14

Movement Alert|INNOVENT BIO Rises 3.21% in Regular Trading, WCLC Data Releases Catalyze Broad Innovative Drug Sector Rally

Market Focus
·
Sep 14

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Stock News
·
Sep 14

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

Movement Alert|INNOVENT BIO Drops 3.11% in Regular Trading, Southbound Funds Continue Selling Amid Biotech Sector Weakness and Insurance Negotiation Uncertainty

Market Focus
·
Sep 10

Movement Alert|INNOVENT BIO Falls 3.01% in Regular Trading, Biotech Sector Under Pressure Amid NRDL Negotiation Uncertainty

Market Focus
·
Sep 08

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Stock News
·
Sep 07

Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors

Stock News
·
Sep 04

Innovent Biologics Grants 59,757 Options and 583,731 Restricted Shares Under 2024 Incentive Scheme

Bulletin Express
·
Sep 01

Innovent Biologics Grants 583,731 Restricted Shares Under 2024 Share Scheme

Reuters
·
Sep 01

Innovent Biologics Files List of Board, Board Committee Members with Disclosure Duties

Reuters
·
Sep 01

Movement Alert|INNOVENT BIO Falls 3.16% in Regular Trading, Post-Earnings Profit-Taking Continues as Biotech Sector Sells Off Broadly

Market Focus
·
Aug 31

China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices

Reuters
·
Aug 28

Earnings Beat: Innovent Biologics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.
·
Aug 28

Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares

Reuters
·
Aug 27

Nomura Adjusts Innovent Biologics' Price Target to HK$125 From HK$105, Keeps at Buy

MT Newswires Live
·
Aug 27